The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR4E.L Regulatory News (R4E)

  • There is currently no data for R4E

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

r4e granted 17% shareholding in digital platform

23 Jan 2014 07:00

RNS Number : 3101Y
Reach4Entertainment Enterprises PLC
23 January 2014
 



23 January 2014

reach4entertainment enterprises plc

('r4e')

r4e granted 17 per cent shareholding innew digital theatre and arts entertainment platform

r4e, the transatlantic media and entertainment marketing company, today announces that it has been granted a 17 per cent shareholding in Stage17 Incorporated ('Stage17') in lieu of support provided by r4e to Stage 17 during its development.

Stage 17 is a rich digital platform that will deliver a range of Broadway and arts related entertainment content. Content will include original and curated video entertainment programming, aimed at a target audience (25-54 year old, primarily female demographic with a demonstrated interest in theatre and the arts), for whom quality, originality, ease of use and sense of community are paramount.

Stage 17, which has been funded and developed by Stoller Family Partners, of which David Stoller, Executive Chairman of r4e is a general partner, will launch in the first half of 2014, although a teaser trailer can be viewed now at http://www.stage17.tv/preview. Its initial focus will be on the North American market. In the short to medium-term, Stage 17's strategic goal is to monetise its offering through a combination of digital advertising, premium membership subscriptions and e-commerce that will be integrated into its digital platform.

r4e will be a preferred supplier of advertising services, marketing and technical support to Stage 17.

As David Stoller is a director of r4e, the Stage 17 transaction is deemed to be a related party transaction under the AIM Rules. As such, the independent directors of the Company, being Richard Ingham and Marcus Yeoman, having consulted with Cantor Fitzgerald Europe, believe that the terms of the Stage 17 transaction are fair and reasonable in so far as the shareholders are concerned.

David Stoller, Executive Chairman, r4e, said:

"Stage 17 has enormous potential to fill the gap in digital theatre and arts entertainment services for what is a vast addressable market. It is estimated that the target demographic community - primarily individuals aged 25-54 with a demonstrated interest in theatre and the arts - for Stage 17 stands at 136 million in the USA, the UK and Australia alone.

"The combination of a very substantial target market and the growing trend of digital advertising spend which, in the USA alone, amounted to $40 billion in 2013 and is forecast to grow to around $100 billion by 2017, presents a very exciting business opportunity.

"This initiative complements the current service offering from r4e's market leading theatre and entertainment branding, design and advertising agencies, presenting an additional and alternative route to market for them to promote their current clients and develop new digital entertainment and media clients generating additional revenues, whilst also offering further exciting opportunities for additional digital platforms and new strategic partnerships."

Ends

Enquiries:

reach4entertainment +44 (0) 20 7968 1655

David Stoller, Executive Chairman

Sarah Hall, Chief Operating Officer

Blythe Weigh Communications +44 (0) 20 7138 3204

Paul Weigh +44 (0) 7989 129658

Eleanor Parry +44 (0) 7551 293620

Cantor Fitzgerald Europe +44 (0) 20 7894 7000

Mark Percy (Corporate Finance)

David Banks / Paul Jewell (Corporate Broking)

 

Allenby Capital +44 (0) 20 3328 5656

 

Katrina Perez/Kelly Gardiner

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZMGZMMZRGDZZ
Date   Source Headline
2nd Sep 20206:31 pmRNSHolding(s) in Company
27th Aug 20205:30 pmRNSReach4entertainment Enterprises
25th Aug 202011:04 amRNSHolding(s) in Company
21st Aug 20204:54 pmRNSResult of GM and cancellation from AIM
20th Aug 20207:42 amRNSClaim
18th Aug 20207:00 amRNSDirector shareholding
14th Aug 20207:00 amRNSDirector shareholding
13th Aug 20208:38 amRNSHolding(s) in Company
10th Aug 20205:30 pmRNSHolding(s) in Company
10th Aug 202011:01 amRNSHolding(s) in Company
10th Aug 202011:00 amRNSHolding(s) in Company
7th Aug 20203:03 pmRNSDirector/PDMR Dealing
7th Aug 20209:23 amRNSDirector shareholding - Replacement
7th Aug 20207:00 amRNSDirector shareholding
6th Aug 20205:30 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
4th Aug 20207:00 amRNSProposed cancellation of AIM admission
4th Aug 20207:00 amRNSTotal Voting Rights
21st Jul 20204:44 pmRNSResult of GM
3rd Jul 20207:00 amRNSTotal Voting Rights
1st Jul 20209:06 amRNSAIM Rule 17 and Schedule 2(g) update
30th Jun 20202:49 pmRNSResult of AGM
30th Jun 20207:00 amRNSNotice of GM
29th Jun 20207:00 amRNSFinal Results
5th Jun 202010:17 amRNSNotice of AGM
4th Jun 20207:00 amRNSTotal Voting Rights
7th May 20207:00 amRNSCOVID-19 Update
4th May 20207:00 amRNSTotal Voting Rights
3rd Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSCovid-19 (Coronavirus) update statement
4th Mar 20207:00 amRNSBlock Listing Six Monthly Return
4th Mar 20207:00 amRNSTotal Voting Rights
18th Feb 20207:00 amRNSYear-end trading update
4th Feb 20207:00 amRNSTotal Voting Rights
3rd Jan 20207:00 amRNSTotal Voting Rights
4th Dec 20197:00 amRNSTotal Voting Rights
4th Nov 20197:00 amRNSTotal Voting Rights
4th Oct 20197:00 amRNSTotal Voting Rights
30th Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSTotal voting rights
2nd Aug 20197:00 amRNSTotal Voting Rights
30th Jul 201911:55 amRNSCapital Reduction Update
16th Jul 20194:01 pmRNSCapital Reduction Update
11th Jul 20191:43 pmRNSHolding(s) in Company
9th Jul 20194:34 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSTotal Voting Rights
28th Jun 201911:24 amRNSResult of AGM
7th Jun 20197:00 amRNSCorporate Update re. Dewynters Germany
4th Jun 20197:00 amRNSTotal voting rights
3rd Jun 20197:00 amRNSAnnual Report, AGM and Proposed Capital Reduction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.